Abstract
The brain overlapping system-level architecture is associated with functional information integration in the multiple roles of the same region, and it has been developed as an underlying novel biomarker of brain disease and may characterise the indicators for the treatment of Alzheimer’s disease (AD). However, it remains uncertain whether these changes are influenced by external magnetic stimulation and internal gene expression. A total of 73 AD-spectrum patients (52 with true stimulation and 21 with sham stimulation) were underwent four-week neuronavigated transcranial magnetic stimulation (rTMS). Shannon-entropy diversity coefficient analysis was used to explore the brain overlapping system of the neuroimaging data in these pre- and posttreatment patients. Transcription-neuroimaging association analysis was further performed via gene expression data from the Allen Human Brain Atlas. Compared with the rTMS_sham stimulation group, the rTMS_true stimulation group achieved the goal of cognitive improvement through the reconstruction of functional information integration in the multiple roles of 27 regions associated with the brain overlapping system, involving the attentional network, sensorimotor network, default mode network and limbic network. Furthermore, these overlapping regions were closely linked to gene expression on cellular homeostasis and immune inflammation, and support vector regression analysis revealed that the baseline diversity coefficients of the attentional and sensorimotor networks can effectively predict memory improvement after rTMS treatment. These findings highlight the brain overlapping system associated with cognitive improvement, and provide the first evidence that external magnetic stimulation and internal gene expression could influence these overlapping regions in AD-spectrum patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout







Similar content being viewed by others
Data availability
Data supporting the findings of this study are available from the corresponding author upon request. The data are not publicly available because they contain information that could compromise the privacy of the research participants.
References
Ogbodo JO, Agbo CP, Njoku UO, Ogugofor MO, Egba SI, Ihim SA, et al. Alzheimer’s disease: pathogenesis and therapeutic interventions. Curr Aging Sci. 2022;15:2–25.
Passeri E, Elkhoury K, Morsink M, Broersen K, Linder M, Tamayol A, et al. Alzheimer’s disease: treatment strategies and their limitations. Int J Mol Sci. 2022;23:13954.
Di Lorenzo F, Motta C, Casula EP, Bonnì S, Assogna M, Caltagirone C, et al. LTP-like cortical plasticity predicts conversion to dementia in patients with memory impairment. Brain Stimul. 2020;13:1175–82.
McNerney MW, Kraybill EP, Narayanan S, Mojabi FS, Venkataramanan V, Heath A. Memory-related hippocampal brain-derived neurotrophic factor activation pathways from repetitive transcranial magnetic stimulation in the 3xTg-AD mouse line. Exp Gerontol. 2023;183:112323.
Dennis EL, Thompson PM. Functional brain connectivity using fMRI in aging and Alzheimer’s disease. Neuropsychol Rev. 2014;24:49–62.
Nabizadeh F. Disruption in functional networks mediated tau spreading in Alzheimer’s disease. Brain Commun. 2024;6:fcae198.
Guo T, Zhang Y, Xue Y, Qiao L, Shen D. Brain function network: higher order vs. more discrimination. Front Neurosci. 2021;15:696639.
Bai F, Zhang Z, Watson DR, Yu H, Shi Y, Yuan Y, et al. Abnormal functional connectivity of hippocampus during episodic memory retrieval processing network in amnestic mild cognitive impairment. Biol Psychiatry. 2009;65:951–8.
Chen X, Zhang H, Gao Y, Wee CY, Li G, Shen D. High-order resting-state functional connectivity network for MCI classification. Hum Brain Mapp. 2016;37:3282–96.
Schuurman T, Bruner E. Modularity and community detection in human brain morphology. Anat Rec (Hoboken). 2024;307:345–55.
Asghari K, Niknam Z, Mohammadpour-Asl S, Chodari L. Cellular junction dynamics and Alzheimer’s disease: a comprehensive review. Mol Biol Rep. 2024;51:273.
Dai Z, Yan C, Li K, Wang Z, Wang J, Cao M, et al. Identifying and mapping connectivity patterns of brain network hubs in Alzheimer’s disease. Cereb Cortex. 2015;25:3723–42.
Lee WJ, Cho H, Baek MS, Kim HK, Lee JH, Ryu YH, et al. Dynamic network model reveals distinct tau spreading patterns in early- and late-onset Alzheimer disease. Alzheimers Res Ther. 2022;14:121.
Lei T, Liao X, Liang X, Sun L, Xia M, Xia Y, et al. Functional network modules overlap and are linked to interindividual connectome differences during human brain development. PLoS Biol. 2024;22:e3002653.
Faskowitz J, Esfahlani FZ, Jo Y, Sporns O, Betzel RF. Edge-centric functional network representations of human cerebral cortex reveal overlapping system-level architecture. Nat Neurosci. 2020;23:1644–54.
Jo Y, Zamani Esfahlani F, Faskowitz J, Chumin EJ, Sporns O, Betzel RF. The diversity and multiplexity of edge communities within and between brain systems. Cell Rep. 2021;37:110032.
Gu Y, Li L, Zhang Y, Ma J, Yang C, Xiao Y, et al. The overlapping modular organization of human brain functional networks across the adult lifespan. Neuroimage. 2022;253:119125.
Rubinov M, Sporns O. Weight-conserving characterization of complex functional brain networks. Neuroimage. 2011;56:2068–79.
MartĂnez GarcĂa SJ, Padilla Longoria P. Analysis of Shannon’s entropy to contrast between the Embodied and Neurocentrist hypothesis of conscious experience. Biosystems. 2024;246:105323.
Sirkis DW, Bonham LW, Johnson TP, La Joie R, Yokoyama JS. Dissecting the clinical heterogeneity of early-onset Alzheimer’s disease. Mol Psychiatry. 2022;27:2674–88.
Chhetri A, Goel K, Ludhiadch A, Singh P, Munshi A. Role of imaging genetics in Alzheimer’s disease: a systematic review and current update. CNS Neurol Disord Drug Targets. 2024;23:1143–56.
Estevez-Fraga C, Altmann A, Parker CS, Scahill RI, Costa B, Chen Z, et al. Genetic topography and cortical cell loss in Huntington’s disease link development and neurodegeneration. Brain. 2023;146:4532–46.
Baik JY, Kim M, Bao J, Long Q, Shen L. Identifying Alzheimer’s genes via brain transcriptome mapping. BMC Med Genomics. 2022;15:116.
Anand C, Torok J, Abdelnour F, Maia PD, Raj A. Selective vulnerability and resilience to Alzheimer’s disease tauopathy as a function of genes and the connectome. bioRxiv. 2024.
Ye F, Funk Q, Rockers E, Shulman JM, Masdeu JC, Pascual B. In Alzheimer-prone brain regions, metabolism and risk-gene expression are strongly correlated. Brain Commun. 2022;4:fcac216.
Chen L, Zhao S, Wang Y, Niu X, Zhang B, Li X, et al. Genetic insights into obesity and brain: combine mendelian randomization study and gene expression analysis. Brain Sci. 2023;13:892.
Yao W, Hou X, Zhou H, You S, Lv T, Chen H, et al. Associations between the multitrajectory neuroplasticity of neuronavigated rTMS-mediated angular gyrus networks and brain gene expression in AD spectrum patients with sleep disorders. Alzheimers Dement. 2024;20:7885–901.
Chen HF, Sheng XN, Yang ZY, Shao PF, Xu HH, Qin RM, et al. Multi-networks connectivity at baseline predicts the clinical efficacy of left angular gyrus-navigated rTMS in the spectrum of Alzheimer’s disease: a sham-controlled study. CNS Neurosci Ther. 2023;29:2267–80.
McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr., Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–9.
Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183–94.
Chen J, Bardes EE, Aronow BJ, Jegga AG. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 2009;37:W305–311.
Dougherty JD, Schmidt EF, Nakajima M, Heintz N. Analytical approaches to RNA profiling data for the identification of genes enriched in specific cells. Nucleic Acids Res. 2010;38:4218–30.
Xu X, Wells AB, O’Brien DR, Nehorai A, Dougherty JD. Cell type-specific expression analysis to identify putative cellular mechanisms for neurogenetic disorders. J Neurosci. 2014;34:1420–31.
Peng B, Zhao Y, Li X, Dong K, Li T, Liu D, et al. Understanding the effects of different transcranial magnetic stimulation control protocols: a behavioral and neural perspective. J Neurophysiol. 2024;132:1977–85.
Betzel RF, Bassett DS. Multi-scale brain networks. Neuroimage. 2017;160:73–83.
Dai Z, Lin Q, Li T, Wang X, Yuan H, Yu X, et al. Disrupted structural and functional brain networks in Alzheimer’s disease. Neurobiol Aging. 2019;75:71–82.
Jin S, Wang J, He Y. The brain network hub degeneration in Alzheimer’s disease. Biophys Rep. 2024;10:213–29.
Rodriguez RX, Noble S, Tejavibulya L, Scheinost D. Leveraging edge-centric networks complements existing network-level inference for functional connectomes. Neuroimage. 2022;264:119742.
Chumin EJ, Faskowitz J, Esfahlani FZ, Jo Y, Merritt H, Tanner J, et al. Cortico-subcortical interactions in overlapping communities of edge functional connectivity. Neuroimage. 2022;250:118971.
Kabbara A, Paban V, Hassan M. The dynamic modular fingerprints of the human brain at rest. Neuroimage. 2021;227:117674.
Lazarov O, Gupta M, Kumar P, Morrissey Z, Phan T. Memory circuits in dementia: The engram, hippocampal neurogenesis and Alzheimer’s disease. Prog Neurobiol. 2024;236:102601.
Bråthen ACS, de Lange AG, Rohani DA, Sneve MH, Fjell AM, Walhovd KB. Multimodal cortical and hippocampal prediction of episodic-memory plasticity in young and older adults. Hum Brain Mapp. 2018;39:4480–92.
Arulchelvan E, Vanneste S. Promising neurostimulation routes for targeting the hippocampus to improve episodic memory: a review. Brain Res. 2023;1815:148457.
Wang JX, Rogers LM, Gross EZ, Ryals AJ, Dokucu ME, Brandstatt KL, et al. Targeted enhancement of cortical-hippocampal brain networks and associative memory. Science. 2014;345:1054–7.
Lawn T, Howard MA, Turkheimer F, Misic B, Deco G, Martins D, et al. From neurotransmitters to networks: transcending organisational hierarchies with molecular-informed functional imaging. Neurosci Biobehav Rev. 2023;150:105193.
Su J, Song Y, Zhu Z, Huang X, Fan J, Qiao J, et al. Cell-cell communication: new insights and clinical implications. Signal Transduct Target Ther. 2024;9:196.
Lee CY, Riffle D, Xiong Y, Momtaz N, Lei Y, Pariser JM, et al. Characterizing dysregulations via cell-cell communications in Alzheimer’s brains using single-cell transcriptomes. BMC Neurosci. 2024;25:24.
Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;575:669–73.
Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17:157–72.
Bouakaz L, Bouakaz E, Murgola EJ, Ehrenberg M, Sanyal S. The role of ribosomal protein L11 in class I release factor-mediated translation termination and translational accuracy. J Biol Chem. 2006;281:4548–56.
Slomnicki LP, Hallgren J, Vashishta A, Smith SC, Ellis SR, Hetman M. Proapoptotic requirement of ribosomal protein L11 in ribosomal stress-challenged cortical neurons. Mol Neurobiol. 2018;55:538–53.
Matsutake T, Srivastava PK. The immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein. Proc Natl Acad Sci USA. 2001;98:3992–7.
Qin H, Hu C, Zhao X, Tian M, Zhu B. Usefulness of candidate mRNAs and miRNAs as biomarkers for mild cognitive impairment and Alzheimer’s disease. Int J Neurosci. 2023;133:89–102.
Qiu C, Xu H. A six-gene signature related to liquid-liquid phase separation for diagnosis of Alzheimer’s disease. Actas Esp Psiquiatr. 2024;52:759–68.
Pérez-Oliveira S, Castilla-Silgado J, Painous C, Aldecoa I, Menéndez-González M, Blázquez-Estrada M, et al. Huntingtin CAG repeats in neuropathologically confirmed tauopathies: Novel insights. Brain Pathol. 2024;34:e13250.
Axenhus M, Winblad B, Tjernberg LO, Schedin-Weiss S. Huntingtin levels are elevated in hippocampal post-mortem samples of Alzheimer’s disease brain. Curr Alzheimer Res. 2020;17:858–67.
Acknowledgements
This study was supported partly by grants from the National Natural Science Foundation of China (No. 82371437), the Key Research and Development Program of Jiangsu Province (No. BE2023674), and Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University (No. 2022-LCYG-MS-05).
Author information
Authors and Affiliations
Contributions
WY and FB contributed to the conception and design of the study. WY, XH and WZ performed the analyses, obtained the findings and provided guidance on the interpretation of the results. WY, XH, WZ and XS were involved in the collection of the data. WY, FB and JZ wrote the manuscript and supervised the study.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
The study protocol was approved by the Ethics Committee of Drum Tower Hospital of Nanjing University. All participants submitted their written informed consent to participate before the recruitment.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yao, W., Hou, X., Zheng, W. et al. Brain overlapping system-level architecture influenced by external magnetic stimulation and internal gene expression in AD-spectrum patients. Mol Psychiatry 30, 4110–4121 (2025). https://doi.org/10.1038/s41380-025-02991-5
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41380-025-02991-5


